The Choay domain -: the structure responsible for the anticoagulant action of heparins

被引:3
|
作者
Hemker, HC [1 ]
Al Dieri, R [1 ]
Wagenvoord, R [1 ]
Béguin, S [1 ]
机构
[1] Univ Maastricht, Cardiovasc Res Inst, Fac Med, NL-6200 MD Maastricht, Netherlands
来源
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE | 2003年 / 187卷 / 01期
关键词
heparin; polysaccharides; thrombin; antithrombins;
D O I
10.1016/S0001-4079(19)34080-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe the common structural basis for the anticoagulant action of the many different heparins available to the clinician. From different types of heparin we prepared fractions of virtually single molecular weight. We determined the molar concentration of material (HAM) containing the antithrombin (AT) binding pentasaccharide (A-domain), the specific catalytic activity in thrombin- and factor Xa inactivation and the capacity to inhibit thrombin generation (TG). We also calculated the molar concentration of A-domain with 12 sugar units at its non-reducing end, i.e. the structure that carries anti-thrombin activity (Choay- or C-domain). The anti-thrombin activity and the effects on TG are determined by the concentration of C-domain and independent of the source material or Mr. High Mr fractions (> 15.000) are less active, probably through interaction with non-AT plasma proteins. Anti factor Xa activity is not indicative of anticoagulant potency but is a sensitive indicator of Mr and therefore predicts favourable pharmacokinetic properties : long half-life in the circulation and high bioavailability.
引用
收藏
页码:59 / 66
页数:8
相关论文
共 50 条
  • [1] The Choay domain - the structure responsible for the anticoagulant action of heparins - Discussion
    Blancher, G
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2003, 187 (01): : 66 - 67
  • [2] THE ANTICOAGULANT MODE OF ACTION OF HEPARINS
    LINDHOUT, T
    BEGUIN, S
    SCHOEN, P
    HEMKER, HC
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 871 - 871
  • [3] A COMPARATIVE-STUDY ON THE MECHANISM OF THE ANTICOAGULANT ACTION OF MOLLUSK AND MAMMALIAN HEPARINS
    PAIVA, JF
    SANTOS, EA
    JESKE, W
    FAREED, J
    NADER, HB
    DIETRICH, CP
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-PHYSIOLOGY, 1995, 111 (03): : 495 - 499
  • [4] Analysis of the Action of Quaternized Chitosans with Different Molecular Weight on Anticoagulant Activity of Heparins In Vitro
    Drozd, N. N.
    Logvinova, Yu. S.
    Shagdarova, B. Ts.
    Il'ina, A. V.
    Varlamov, V. P.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2019, 167 (02) : 279 - 283
  • [5] Analysis of the Action of Quaternized Chitosans with Different Molecular Weight on Anticoagulant Activity of Heparins In Vitro
    N. N. Drozd
    Yu. S. Logvinova
    B. Ts. Shagdarova
    A. V. Il’ina
    V. P. Varlamov
    Bulletin of Experimental Biology and Medicine, 2019, 167 : 279 - 283
  • [6] Reversal for heparins and new anticoagulant treatments
    Kortchinsky, T.
    Vigue, B.
    Samama, C. M.
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2013, 32 (01): : 37 - 49
  • [7] Engineered heparins as new anticoagulant drugs
    Vaidyanathan, Deepika
    Williams, Asher
    Dordick, Jonathan S.
    Koffas, Mattheos A. G.
    Linhardt, Robert J.
    BIOENGINEERING & TRANSLATIONAL MEDICINE, 2017, 2 (01) : 17 - 30
  • [8] ANTICOAGULANT ACTIVITIES OF LUNG AND MUCOUS HEPARINS
    BARROWCLIFFE, TW
    JOHNSON, EA
    EGGLETON, CA
    THOMAS, DP
    THROMBOSIS RESEARCH, 1978, 12 (01) : 27 - 36
  • [9] THE ANTICOAGULANT ACTIVITY OF HEPARINS IN DEXTROSE SOLUTIONS
    ANDERSON, W
    HARTHILL, JE
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1982, 34 (02) : 90 - 96
  • [10] THE ANTICOAGULANT ACTIVITY OF DERIVATIZED AND IMMOBILIZED HEPARINS
    EBERT, CD
    LEE, ES
    DENERIS, J
    KIM, SW
    ADVANCES IN CHEMISTRY SERIES, 1982, (199): : 161 - 176